Cargando…
The place for short-acting opioids: special emphasis on remifentanil
Pain is among the worst possible experiences for the critically ill. Therefore, nearly all intensive care patients receive some kind of pain relief, and opioids are most frequently administered. Morphine has a number of important adverse effects, including histamine release, pruritus, constipation,...
Autores principales: | Wilhelm, Wolfram, Kreuer, Sascha |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2391266/ https://www.ncbi.nlm.nih.gov/pubmed/18495056 http://dx.doi.org/10.1186/cc6152 |
Ejemplares similares
-
Pain Management in Intensive Care Unit Patients: The Role of Ultra-Short Acting Opioid: Remifentanil
por: Khan, Zahid Hussain
Publicado: (2013) -
Genetic variation in the serotonin transporter gene (5-HTTLPR, rs25531) influences the analgesic response to the short acting opioid Remifentanil in humans
por: Kosek, Eva, et al.
Publicado: (2009) -
Recovery in Special Emphasis Populations
por: Wagner, Eric F., et al.
Publicado: (2020) -
Management of Familial Hypercholesterolemia with Special Emphasis on Evinacumab
por: Krzemińska, Julia, et al.
Publicado: (2022) -
Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review
por: Kim, Sang Hun, et al.
Publicado: (2014)